Developing psychedelic-based therapies for mental health disorders, the company is focused on psilocybin-assisted treatment for conditions such as treatment‑resistant depression. Its lead candidate, COMP360, is in late-stage clinical development and is being evaluated alongside psychological support...
1 member of Congress has disclosed 1 trade in COMPASS Pathways plc (CMPS), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-01-23 | Shri Thanedar | sell | $1K – $15K |